Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial metal-dependent enzymes and membranes represent a broad category of biological structures and proteins essential for the survival and virulence of pathogenic microorganisms. Metal-dependent enzymes, or metalloenzymes, utilize metal ions such as zinc, iron, or manganese as essential cofactors for catalytic activities, including the hydrolysis of beta-lactam antibiotics by metallo-beta-lactamases and the removal of N-terminal formyl groups by peptide deformylases (Bush, 1998; Giglione et al., 2000). Microbial membranes, including the cytoplasmic membrane and the outer membrane of Gram-negative bacteria, maintain cellular integrity and regulate ion homeostasis (Straus & Hancock, 2006). Drugs targeting these entities include membrane-disrupting lipopeptides like daptomycin and polymyxins, as well as experimental inhibitors that sequester metal ions or bind to the active sites of metalloenzymes (Velkov et al., 2010; King et al., 2014). A major challenge in targeting these components is achieving sufficient selectivity to avoid cross-reactivity with human membranes or host metalloenzymes, which can result in significant toxicities such as nephrotoxicity or neurotoxicity (Falagas & Kasiakou, 2006). This target group is particularly relevant in the context of multi-drug resistant (MDR) infections where traditional antibiotic targets have been bypassed.
Drugs targeting this group act either by physically disrupting the microbial lipid bilayer, leading to cytoplasmic leakage and cell death, or by inhibiting metal-dependent enzymes through the chelation of essential metal cofactors or competitive inhibition of the active site.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial metal-dependent enzymes and membranes.